Back
Regeneron Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Buy
66
REGN
Regeneron Pharmaceuticals
Last Price:
967.70
Seasonality Move:
8.1%
Buy
68
LLY
Eli Lilly and
Last Price:
770.00
Seasonality Move:
1.62%
Buy
66
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $978.21. The Score for REGN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $787.02. The Score for LLY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $978.21
The current trend is moderately bullish and REGN is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $787.02
The current trend is moderately bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.94 | Buy |
| Relative Strength Index (14 RSI): | 64.91 | Buy |
| Chaikin Money Flow: | 29321 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (891.11 - 960.35) | Buy |
| Bollinger Bands (100): | (905.72 - 972.14) | Buy |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.87 | Buy |
| Relative Strength Index (14 RSI): | 59.1 | Buy |
| Chaikin Money Flow: | 2572047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (736.04 - 771.56) | Buy |
| Bollinger Bands (100): | (652.56 - 784.72) | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 970.75 | Buy |
| 20-day SMA: | 931.23 | Buy |
| 50-day SMA: | 942.71 | Buy |
| 200-day SMA: | 878.28 | Buy |
| 8-day EMA: | 967.15 | Buy |
| 20-day EMA: | 947.44 | Buy |
| 50-day EMA: | 939.46 | Buy |
| 200-day EMA: | 885.08 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 769.96 | Buy |
| 20-day SMA: | 754.27 | Buy |
| 50-day SMA: | 760.64 | Buy |
| 200-day SMA: | 642.83 | Buy |
| 8-day EMA: | 768.03 | Buy |
| 20-day EMA: | 761.49 | Buy |
| 50-day EMA: | 751.11 | Buy |
| 200-day EMA: | 648.71 | Buy |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.59 per share, and an increase next year of $3.24 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, a decrease next quarter of $0.30 per share, an increase this year of $7.49 per share, and an increase next year of $5.15 per share.
Regeneron Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||